Nandita M deSouza
Overview
Explore the profile of Nandita M deSouza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
deSouza N, Gedroyc W, Rivens I, Ter Haar G
Front Oncol
. 2022 Nov;
12:1037959.
PMID: 36387108
High-intensity focused ultrasound can ablate a target permanently, leaving tissues through which it passes thermally unaffected. When delivered under magnetic resonance (MR) imaging guidance, the change in tissue relaxivity on...
12.
Huang E, Pennello G, deSouza N, Wang X, Buckler A, Kinahan P, et al.
Acad Radiol
. 2022 Oct;
30(2):196-214.
PMID: 36273996
Combinations of multiple quantitative imaging biomarkers (QIBs) are often able to predict the likelihood of an event of interest such as death or disease recurrence more effectively than single imaging...
13.
Delfino J, Pennello G, Barnhart H, Buckler A, Wang X, Huang E, et al.
Acad Radiol
. 2022 Oct;
30(2):183-195.
PMID: 36202670
This manuscript is the third in a five-part series related to statistical assessment methodology for technical performance of multi-parametric quantitative imaging biomarkers (mp-QIBs). We outline approaches and statistical methodologies for...
14.
deSouza N, van der Lugt A, Deroose C, Alberich-Bayarri A, Bidaut L, Fournier L, et al.
Insights Imaging
. 2022 Oct;
13(1):159.
PMID: 36194301
Background: Lesion/tissue segmentation on digital medical images enables biomarker extraction, image-guided therapy delivery, treatment response measurement, and training/validation for developing artificial intelligence algorithms and workflows. To ensure data reproducibility, criteria...
15.
Obuchowski N, Huang E, deSouza N, Raunig D, Delfino J, Buckler A, et al.
Acad Radiol
. 2022 Sep;
30(2):147-158.
PMID: 36180328
Multiparameter quantitative imaging incorporates anatomical, functional, and/or behavioral biomarkers to characterize tissue, detect disease, identify phenotypes, define longitudinal change, or predict outcome. Multiple imaging parameters are sometimes considered separately but...
16.
Tree A, Satchwell L, Alexander E, Blasiak-Wal I, deSouza N, Gao A, et al.
Int J Radiat Oncol Biol Phys
. 2022 Sep;
115(2):305-316.
PMID: 36150450
Purpose: Our purpose was to report 5-year efficacy and toxicity of intraprostatic lesion boosting using standard and hypofractionated radiation therapy. Methods And Materials: DELINEATE (ISRCTN 04483921) is a single center...
17.
Wormald B, Moser N, deSouza N, Mantikas K, Malpartida-Cardenas K, Pennisi I, et al.
Sci Rep
. 2022 May;
12(1):8750.
PMID: 35610285
Cervical cancer affects over half a million people worldwide each year, the majority of whom are in resource-limited settings where cytology screening is not available. As persistent human papilloma virus...
18.
Gagliardi T, Adejolu M, deSouza N
J Clin Med
. 2022 Mar;
11(6).
PMID: 35329850
Detection, characterization, staging, and response assessment are key steps in the imaging pathway of ovarian cancer. The most common type, high grade serous ovarian cancer, often presents late, so that...
19.
Fournier L, de Geus-Oei L, Regge D, Oprea-Lager D, DAnastasi M, Bidaut L, et al.
Front Oncol
. 2022 Jan;
11:800547.
PMID: 35083155
Response evaluation criteria in solid tumours (RECIST) v1.1 are currently the reference standard for evaluating efficacy of therapies in patients with solid tumours who are included in clinical trials, and...
20.
Oprea-Lager D, Cysouw M, Boellaard R, Deroose C, de Geus-Oei L, Lopci E, et al.
Front Oncol
. 2021 Dec;
11:772530.
PMID: 34869009
Metastatic tumor deposits in bone marrow elicit differential bone responses that vary with the type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can change...